538
Views
18
CrossRef citations to date
0
Altmetric
Reviews

Issues in drug metabolism of major antihypertensive drugs: β-blockers, calcium channel antagonists and angiotensin receptor blockers

, PhD, , &
Pages 199-211 | Published online: 22 Jan 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Christian Höcht, Facundo Martín Bertera, Julieta Sofía Del Mauro & Carlos Alberto Taira. (2014) Models for evaluating the pharmacokinetics and pharmacodynamics for β-blockers. Expert Opinion on Drug Metabolism & Toxicology 10:4, pages 525-541.
Read now
Sze Wa Chan, Miao Hu & Brian Tomlinson. (2012) The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure. Expert Opinion on Drug Metabolism & Toxicology 8:7, pages 767-790.
Read now

Articles from other publishers (16)

Pallavi SwarupGopal Prasad Agrawal. (2021) Solid Dispersion: A Mechanistic and Realistic Approach on Antihypertensive Drug as a Drug Carrier System. ASSAY and Drug Development Technologies 19:5, pages 282-289.
Crossref
Ru-Qiang Yuan, Lei Qian, Wei-Jing Yun, Xiao-Hui Cui, Guang-Xin Lv, Wei-Qi Tang, Ri-Chang Cao & Hu Xu. (2019) Cucurbitacins extracted from Cucumis melo L. (CuEC) exert a hypotensive effect via regulating vascular tone. Hypertension Research 42:8, pages 1152-1161.
Crossref
Aisha N. Iskakova, Aliya A. Romanova, Akbota M. Aitkulova, Nurgul S. Sikhayeva, Elena V. Zholdybayeva & Erlan M. Ramanculov. (2016) Polymorphisms in genes involved in the absorption, distribution, metabolism, and excretion of drugs in the Kazakhs of Kazakhstan. BMC Genetics 17:1.
Crossref
Christian Höcht, Facundo Martín Bertera, Julieta Sofía Del Mauro, Luciano Parola & Carlos Alberto Taira. (2016) PK/PD modeling of β-blockers in cardiovascular disease: an update. International Journal of Pharmacokinetics 1:1, pages 55-68.
Crossref
P Patel, P K C Gupta, C M J White, A G Stanley, B Williams & M Tomaszewski. (2015) Screening for non-adherence to antihypertensive treatment as a part of the diagnostic pathway to renal denervation. Journal of Human Hypertension 30:6, pages 368-373.
Crossref
Giovanna Gentile, Lorenza Chiossi, Luana Lionetto, Paolo Martelletti & Marina Borro. (2014) Pharmacogenetic insights into migraine treatment in children. Pharmacogenomics 15:11, pages 1539-1550.
Crossref
Facundo Martín Bertera, Julieta Sofía Del Mauro, Valeria Lovera, Diego Chiappetta, Ariel Héctor Polizio, Carlos Alberto Taira & Christian Höcht. (2013) Enantioselective pharmacokinetics and cardiovascular effects of nebivolol in L-NAME hypertensive rats. Hypertension Research 37:3, pages 194-201.
Crossref
Branislav Štrauch, Ondřej Petrák, Tomáš Zelinka, Ján Rosa, Zuzana Šomlóová, Tomáš Indra, Lukáš Chytil, Věra Marešová, Ivana Kurcová, Robert Holaj, Dan Wichterle & Jiří Widimský. (2013) Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis. Journal of Hypertension 31:12, pages 2455-2461.
Crossref
Facundo Martín Bertera, Julieta Sofía Del Mauro, Valeria Lovera, Diego Chiappetta, Ariel Héctor Polizio, Carlos Alberto Taira & Christian Höcht. (2013) Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats. Hypertension Research 36:4, pages 349-355.
Crossref
Sze Wa Chan, Miao Hu, Sara Shun Wah Ko, Catherine Wing Yan Tam, Benny Siu Pong Fok, Ophelia Qi Ping Yin, Moses Sing Sum Chow & Brian Tomlinson. (2012) CYP2C19 genotype has a major influence on labetalol pharmacokinetics in healthy male Chinese subjects. European Journal of Clinical Pharmacology 69:4, pages 799-806.
Crossref
Facundo Martín Bertera, Julieta Sofía Del Mauro, Ariel Héctor Polizio, Diego Chiappetta, Carlos Alberto Taira & Christian Höcht. (2012) Effect of nebivolol on beat-to-beat and short-term blood pressure variability in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Archives of Pharmacology 385:8, pages 833-843.
Crossref
Jennifer J. Kiser, James R. Burton, Peter L. Anderson & Gregory T. Everson. (2012) Review and management of drug interactions with boceprevir and telaprevir. Hepatology 55:5, pages 1620-1628.
Crossref
Facundo Martín Bertera, Julieta Sofía Del Mauro, Diego Chiappetta, Ariel Héctor Polizio, Fabián Buontempo, Carlos Alberto Taira & Christian Höcht. (2011) Enantioselective pharmacokinetic and pharmacodynamic properties of carvedilol in spontaneously hypertensive rats: focus on blood pressure variability. Naunyn-Schmiedeberg's Archives of Pharmacology 385:3, pages 325-335.
Crossref
Maamoun Basheer, Herzl Schwalb, Irit Shefler, Lilia Levdansky, Yoseph A. Mekori & Raphael Gorodetsky. (2011) Blood pressure modulation following activation of mast cells by cationic cell penetrating peptides. Peptides 32:12, pages 2444-2451.
Crossref
Henk Visscher, Ursula Amstutz, Johanna Sistonen, Colin J Ross, Michael R Hayden & Bruce C Carleton. (2011) Pharmacogenomics of Cardiovascular Drugs and Adverse Effects in Pediatrics. Journal of Cardiovascular Pharmacology 58:3, pages 228-239.
Crossref
Thomas N. Kakuda, Monika Schöller-Gyüre & Richard M.W. Hoetelmans. (2011) Pharmacokinetic Interactions between Etravirine and Non-Antiretroviral Drugs. Clinical Pharmacokinetics 50:1, pages 25-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.